WBC SPECT/CT Outperforms MRI in Early Detection of Diabetic Foot Osteomyelitis, Study Finds

Highlights

• WBC SPECT/CT achieved 85% sensitivity and 79% specificity for initial diagnosis versus MRI’s 73% sensitivity and 43% specificity

• After antibiotic treatment, both imaging modalities demonstrated identical performance with 75% sensitivity and specificity

• This is the first prospective study using paired bone biopsy validation before and after antibiotic intervention

• Findings support WBC SPECT/CT as the preferred first-line non-invasive imaging modality for suspected diabetic foot osteomyelitis

Background: The Clinical Challenge of Diabetic Foot Osteomyelitis

Diabetic foot osteomyelitis represents one of the most challenging complications in patients with diabetes mellitus, serving as a leading cause of lower limb amputations worldwide. The infection typically develops from contiguous spread from a skin ulcer, making early and accurate diagnosis crucial for preventing tissue destruction and avoiding unnecessary surgical interventions.

The management of diabetic foot osteomyelitis requires a delicate balance between aggressive antimicrobial therapy and conservative wound care. Misdiagnosis can lead to either overtreatment with prolonged antibiotic courses and associated complications or undertreatment resulting in progressive bone destruction and eventual amputation. Consequently, the choice of diagnostic imaging modality carries significant clinical implications for patient outcomes.

Conventional magnetic resonance imaging has long been considered the imaging modality of choice for suspected osteomyelitis due to its excellent soft tissue contrast and ability to detect marrow edema. However, MRI has known limitations, particularly in post-treatment scenarios where inflammatory changes may persist even after successful therapy. White blood cell SPECT/CT combines functional nuclear medicine imaging with anatomical computed tomography, potentially offering advantages in both sensitivity and specificity for bone infection detection.

Study Design and Methodology

This prospective clinical study enrolled 47 patients presenting with foot wounds clinically suspicious for diabetic foot osteomyelitis at a single academic medical center. All participants underwent both 99mTc-labeled white blood cell single photon emission computed tomography with integrated CT (WBC SPECT/CT) and conventional MRI within a standardized timeframe prior to bone biopsy.

Bone biopsy served as the reference standard, with osteomyelitis defined as positive if either bone cultures or histopathological examination indicated active infection. All imaging studies were interpreted by experienced radiologists blinded to clinical information and biopsy results, who classified each examination as either positive or negative for osteomyelitis.

Following initial diagnostic imaging and biopsy, patients received a standard course of targeted antibiotic therapy based on culture results. Of the original cohort, 20 patients returned for post-treatment evaluation, which included repeat WBC SPECT/CT, MRI, and another bone biopsy to assess therapeutic response. The study design allowed for direct comparison of both imaging modalities at two critical clinical timepoints: initial diagnosis and treatment monitoring.

Diagnostic Performance at Initial Presentation

The results demonstrated substantial differences in diagnostic performance between the two imaging modalities for initial osteomyelitis detection. WBC SPECT/CT achieved a sensitivity of 85% and specificity of 79%, with a positive predictive value of 90% and negative predictive value of 69%. These findings indicate that when WBC SPECT/CT indicates osteomyelitis, the result is correct approximately nine times out of ten.

In contrast, conventional MRI showed considerably lower performance metrics with sensitivity of 73% and specificity of only 43%. The positive predictive value reached 75%, while the negative predictive value was 40%. The notably low specificity of MRI (43%) suggests that this modality frequently identifies abnormalities that do not represent true osteomyelitis, potentially leading to overdiagnosis and unnecessary treatments.

The discrepancy between modalities appears particularly significant in the specificity domain. MRI’s tendency to detect signal abnormalities consistent with infection or inflammation而不代表真正的骨髓炎 may stem from its inherent sensitivity to any process affecting bone marrow water content, including non-infectious inflammatory conditions, post-surgical changes, or Charcot neuropathic osteoarthropathy.

Performance After Antibiotic Treatment

Following completion of antibiotic therapy, both imaging modalities demonstrated unexpected convergence in diagnostic performance. WBC SPECT/CT and MRI achieved identical sensitivity (75%), specificity (75%), positive predictive value (43%), and negative predictive value (92%) in detecting residual infection.

The reduction in WBC SPECT/CT performance after treatment likely reflects the physiological reality that labeled white blood cells continue to accumulate at sites of recent infection even after microbiological cure, as healing bone marrow may still attract inflammatory cells during the remodeling process. Similarly, MRI’s improvement in specificity post-treatment suggests that some non-specific inflammatory changes resolve with successful therapy, reducing false-positive interpretations.

The identical performance metrics after treatment indicate that neither modality can reliably distinguish between residual active infection and sterile inflammatory response during the healing phase. This finding has important clinical implications, suggesting that decisions regarding treatment continuation should rely more heavily on clinical assessment, wound progression, and repeat culture results rather than imaging findings alone.

Clinical Implications for Practice

These findings carry immediate implications for clinical decision-making in diabetic foot osteomyelitis. For initial diagnostic evaluation, WBC SPECT/CT demonstrates clear advantages that justify its consideration as the preferred first-line imaging modality when available. The superior specificity particularly addresses a major clinical concern: avoiding unnecessary antibiotic therapy and potential surgical interventions based on false-positive imaging results.

Healthcare providers managing diabetic foot infections should consider the local availability of nuclear medicine facilities and expertise when establishing diagnostic algorithms. While MRI remains widely available and provides excellent anatomical detail useful for surgical planning, the addition of functional information from WBC SPECT/CT may improve diagnostic confidence, especially in challenging cases where clinical and conventional imaging findings are discordant.

For treatment monitoring, the equivalence of both modalities suggests that either approach may be employed based on institutional resources and patient factors. However, clinicians should exercise caution in interpreting post-treatment imaging, recognizing that residual abnormalities may persist despite microbiological cure.

Study Limitations and Future Directions

Several limitations merit consideration when interpreting these results. The relatively modest sample size, particularly for the post-treatment cohort (n=20), limits the precision of performance estimates for treatment monitoring. Larger prospective studies would strengthen confidence in these preliminary observations.

The single-center design raises questions about generalizability to different patient populations, healthcare settings, or institutions with varying levels of nuclear medicine expertise. Multi-center validation would enhance the external validity of these findings.

Technical factors including variations in MRI protocols, field strength, and sequence parameters may influence diagnostic performance and should be standardized in future investigations. Additionally, the interval between treatment completion and post-treatment imaging was not explicitly specified, which could affect results given the known time course of imaging findings resolution.

Future research should explore the optimal timing of post-treatment imaging, investigate hybrid approaches combining structural and functional imaging, and evaluate whether quantitative analysis of imaging parameters can improve discrimination between active infection and sterile inflammation.

Conclusion

This prospective study provides compelling evidence that WBC SPECT/CT offers superior diagnostic performance compared to conventional MRI for initial evaluation of suspected diabetic foot osteomyelitis. The significant improvement in specificity (79% versus 43%) particularly addresses concerns about overdiagnosis and its associated clinical consequences. While both modalities perform equivalently after antibiotic treatment, the initial diagnostic advantage supports consideration of WBC SPECT/CT as the preferred first-line imaging approach when available.

These findings represent a meaningful advancement in the non-invasive assessment of diabetic foot infections and may help guide more rational utilization of imaging resources in this high-risk population. The validated comparison against bone biopsy in both treatment-naive and post-treatment scenarios provides robust evidence to inform clinical practice guidelines and diagnostic algorithms for diabetic foot osteomyelitis.

Funding and Disclosures

This study received support from institutional research funds at the University of Texas Southwestern Medical Center. The authors reported no conflicts of interest relevant to this research.

References

1. Öz OK, Sherwood AM, Crisologo PA, et al. Prospective comparison of WBC SPECT/CT and conventional MRI for diagnosing osteomyelitis and monitoring treatment response in diabetic foot infections. Diabetologia. 2026;69(4):1049-1059. doi:10.1007/s00125-025-xxxxx

2. Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54(12):e132-e173.

3. Game FL, Jeffcoate WJ. Primarily non-surgical management of osteomyelitis of the foot in diabetes. Diabetologia. 2008;51(6):962-967.

4. van der Bruggen W, Bleeker-Rovers CP, Boerman OC, Gotthardt M, Oyen WJ. SPECT/CT with 99mTc-labeled WBC scintigraphy for diagnostic workup of osteomyelitis. J Nucl Med. 2010;51(7):1115-1122.

5. Arendt-Nielsen L, Chen AC. Magnetic resonance imaging and diagnostic certainty in diabetic foot osteomyelitis. Diabetes Care. 2019;42(9):e142-e144.